VERSARTIS INC's ticker is VSAR and the CUSIP is 92529L102. A total of 109 filers reported holding VERSARTIS INC in Q3 2017. The put-call ratio across all filers is 0.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $3,274,000 | -18.3% | 187,600 | 0.0% | 0.00% | -40.0% |
| Q1 2017 | $4,005,000 | +41.4% | 187,600 | -1.3% | 0.01% | +25.0% |
| Q4 2016 | $2,832,000 | +24.6% | 190,100 | +2.5% | 0.00% | +33.3% |
| Q3 2016 | $2,272,000 | +10.0% | 185,500 | -0.6% | 0.00% | 0.0% |
| Q2 2016 | $2,065,000 | +35.5% | 186,705 | -1.8% | 0.00% | +50.0% |
| Q1 2016 | $1,524,000 | -37.0% | 190,123 | -2.6% | 0.00% | -50.0% |
| Q4 2015 | $2,419,000 | +109.8% | 195,198 | +95.1% | 0.00% | +100.0% |
| Q3 2015 | $1,153,000 | -19.3% | 100,030 | +6.5% | 0.00% | 0.0% |
| Q2 2015 | $1,429,000 | -9.9% | 93,886 | +8.7% | 0.00% | 0.0% |
| Q1 2015 | $1,586,000 | +57.5% | 86,347 | +92.5% | 0.00% | 0.0% |
| Q4 2014 | $1,007,000 | +16.0% | 44,847 | -1.9% | 0.00% | +100.0% |
| Q3 2014 | $868,000 | -28.2% | 45,693 | +6.0% | 0.00% | -50.0% |
| Q2 2014 | $1,209,000 | – | 43,107 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,296,471 | $51,556,000 | 25.09% |
| Aisling Capital LLC | 1,994,568 | $44,778,000 | 6.79% |
| Opaleye Management Inc. | 235,000 | $5,276,000 | 2.67% |
| Perceptive Advisors | 931,171 | $19,740,000 | 1.66% |
| HealthCor Management, L.P. | 875,000 | $19,644,000 | 1.10% |
| Cormorant Asset Management, LP | 200,000 | $4,490,000 | 0.69% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 644,150 | $14,461,000 | 0.63% |
| RA Capital Management | 231,267 | $5,192,000 | 0.56% |
| Baker Brothers Advisors | 2,281,744 | $51,225,000 | 0.52% |
| PFM Health Sciences, LP | 869,463 | $19,519,000 | 0.46% |